Mouse models for dengue vaccines and antivirals

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Dengue virus (DENV) infects 390 million people annually, yet no specific vaccine or antiviral is approved.
• Developing effective DENV vaccines is hindered by the lack of adequate animal models.
• Non-human primates support DENV replication but do not show clinical disease symptoms.

Purpose of the Study:

• To establish a mouse model that accurately reflects severe dengue disease in humans.
• To evaluate the utility of interferon receptor-deficient mice for DENV research.
• To assess the potential of this model for testing dengue vaccine efficacy.

Main Methods:

• Infection of interferon receptor-deficient mice with DENV.
• Observation and analysis of disease manifestations in the mouse model.
• Comparison of disease features with human dengue cases.

Main Results:

• Interferon receptor-deficient mice develop a disease that mirrors key aspects of severe dengue in humans.
• This model allows for the study of DENV pathogenesis.
• The model is suitable for evaluating vaccine-induced immunity.

Conclusions:

• Interferon receptor-deficient mice serve as a valuable model for studying dengue virus infection and disease.
• This model is crucial for the development and testing of DENV vaccines.
• Further research using this model can accelerate the availability of dengue interventions.